✦ LIBER ✦

Effects of single and concurrent intermittent administration of human parathyroid hormone and bisphosphonate cimadronate on bone mineral densities of femur in ovariectomized rats

✍ Scribed by Tasuku Mashiba; Tatsuhiko Tanizawa; Hideaki E. Takahashi; Yuichi Takano; Saburo Nishida; Satoshi Mori; Hiromichi Norimatsu

Publisher: Springer
Year: 1995
Tongue: English
Weight: 535 KB
Volume: 13
Category: Article
ISSN: 0914-8779
DOI: 10.1007/bf01771800

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of intermittent administration of

Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis

✍ Satoru Fukata; Hiroshi Hagino; Toru Okano; Itsuro Yamane; Yasuhiro Kameyama; Ryo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 2 views

## Abstract ## Objective To investigate the effect of intermittent administration of human parathyroid hormone (PTH) on bone mineral density (BMD) and arthritis in rats with collagen‐induced arthritis (CIA). ## Methods Seven‐month‐old female Sprague‐Dawley rats were divided into 4 groups: rats w

Maintaining bone mass by bisphosphonate

Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats

✍ Yuichi Takano; Tatsuhiko Tanizawa; Tasuku Mashiba; Naoto Endo; Saburo Nishida; H 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 791 KB

Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte

Maintenance of bone mineral density of f

Maintenance of bone mineral density of femoral cortex in ovariectomized rats after withdrawal of concurrent administration of human parathyroid hormone (1–34) and incardronate disodium (YM175)

✍ Liu Zhang; Hideaki E. Takahashi; Tatsuhiko Tanizawa; Naoto Endo; Noriaki Yamamot 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 693 KB

Effects of combined and separate intermi

Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia

✍ V. Shen; D. W. Dempster; R. W. E. Mellish; R. Birchman; W. Horbert; R. Lindsay 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 819 KB

To evaluate the potential use of a combination of parathyroid hormone (PTH) and estrogen as therapy for osteoporosis, we examined the effects of combined and separate administration of low-dose PTH and estradiol in ovariectomized rats with established osteopenia. Ovariectomized rats were untreated f

Preserving effect of orally administered

Preserving effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats

✍ T. Österman; L. Laurén; R. Hannuniemi; P. Kuurtamo; R. Sellman; Leiras Oy 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Effects of progesterone on serum levels

Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats

✍ E.I. Barengolts; T. Kouznetsova; A. Segalene; P. Lathon; C. Odvina; S.C. Kukreja 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 867 KB

Local and systemic insulin-like growth factors (IGFs) may be involved in the regulation of bone formation by sex hormones. The present studies describe the in vivo effects of estradiol, progesterone, or both on IGF-1 mRNA abundance in bone, serum IGF-1 levels, and bone formation. Rats were sham-oper